Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Data from clinical trials of GS-9857 support continued clinical evaluation

May 12, 2015

Researchers discover genetic susceptibility locus associated with TB

May 12, 2015

West Nile virus vaccine candidate begins phase I trial

May 11, 2015

Daewoong introduces novel antifungals

May 11, 2015

Claudin-1 as a potential target for HCV infection

May 11, 2015

Wockhardt divulges new antibacterials

May 11, 2015

Symbiomix Therapeutics reports results from phase II trial of SYM-1219 in bacterial vaginosis

May 8, 2015

Replicor discloses phase II data for REP-2139

May 7, 2015

Baxter's Ross River virus vaccine well tolerated in phase III study

May 7, 2015

Theraclone Sciences to screen antibodies from survivors of Ebola virus infection

May 6, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...